1. Home
  2. INO vs RFL Comparison

INO vs RFL Comparison

Compare INO & RFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INO
  • RFL
  • Stock Information
  • Founded
  • INO 1979
  • RFL 2017
  • Country
  • INO United States
  • RFL United States
  • Employees
  • INO N/A
  • RFL N/A
  • Industry
  • INO Medical/Dental Instruments
  • RFL Real Estate
  • Sector
  • INO Health Care
  • RFL Finance
  • Exchange
  • INO Nasdaq
  • RFL Nasdaq
  • Market Cap
  • INO 75.4M
  • RFL 65.4M
  • IPO Year
  • INO 1998
  • RFL N/A
  • Fundamental
  • Price
  • INO $2.08
  • RFL $2.01
  • Analyst Decision
  • INO Buy
  • RFL
  • Analyst Count
  • INO 6
  • RFL 0
  • Target Price
  • INO $17.00
  • RFL N/A
  • AVG Volume (30 Days)
  • INO 1.2M
  • RFL 41.9K
  • Earning Date
  • INO 03-05-2025
  • RFL 03-12-2025
  • Dividend Yield
  • INO N/A
  • RFL N/A
  • EPS Growth
  • INO N/A
  • RFL N/A
  • EPS
  • INO N/A
  • RFL N/A
  • Revenue
  • INO $203,413.00
  • RFL $697,000.00
  • Revenue This Year
  • INO N/A
  • RFL N/A
  • Revenue Next Year
  • INO $2,290.97
  • RFL N/A
  • P/E Ratio
  • INO N/A
  • RFL N/A
  • Revenue Growth
  • INO N/A
  • RFL 151.62
  • 52 Week Low
  • INO $1.74
  • RFL $1.29
  • 52 Week High
  • INO $14.75
  • RFL $2.50
  • Technical
  • Relative Strength Index (RSI)
  • INO 39.63
  • RFL 58.35
  • Support Level
  • INO $1.83
  • RFL $1.83
  • Resistance Level
  • INO $2.39
  • RFL $2.01
  • Average True Range (ATR)
  • INO 0.17
  • RFL 0.15
  • MACD
  • INO 0.11
  • RFL 0.02
  • Stochastic Oscillator
  • INO 51.56
  • RFL 94.44

About INO Inovio Pharmaceuticals Inc.

Inovio Pharmaceuticals Inc is a United States-based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.

About RFL Rafael Holdings Inc. Class B

Rafael Holdings Inc is a holding company with interests in clinical and early-stage pharmaceutical companies. Its primary focus is to expand its investment portfolio through opportunistic investments including therapeutics, which address high unmet medical needs. Through the companies it has invested in, the company is focused on; developing Trappsol Cyclo its clinical program, developing instruments to advance minimally invasive surgeries, preclinical cancer metabolism research operations, and developing pharmaceutical-grade technology Unlokt for third-party cannabis manufacturers. It also holds and manages commercial real estate assets in Jerusalem, Israel. The company's reportable segments are; Infusion Technology, which derives maximum revenue, Healthcare, and Real Estate.

Share on Social Networks: